Relevance of hyperglycemia on the timing of functional loss of allogeneic islet transplants: Implication for mouse model

Transplantation

Volumn 83, Issue 2, 2007, Pages 167-173

  Melzi, Raffaella ^a   Battaglia, Manuela ^a,b   Draghici, Elena ^b   Bonifacio, Ezio ^a   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Hyperglycemia; Islet transplantation; Mouse model

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7D4; RAPAMYCIN; RECOMBINANT INTERLEUKIN 10; TACROLIMUS; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; CELL VOLUME; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; EXPERIMENTAL MODEL; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT REJECTION; HOMEOSTASIS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROBABILITY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FEMALE; HYPERGLYCEMIA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846628497     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000250659.24286.43     Document Type: Article

References (13)

1. Makhlouf L, Duvivier-Kali VF, Bonner-Weir S, et al. Importance of hyperglycemia on the primary function of allogeneic islet transplants. Transplantation 2003; 76(4): 657.
2. Piemonti L, Bertuzzi F, Nano R, et al. Effects of cryopreservation on in vitro and in vivo long-term function of human islets. Transplantation 1999; 68(5): 655.
3. Battaglia M, Stabilini A, Draghici E, et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 2006; 55(1): 40.
4. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412.
5. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343(4): 230.
6. Korsgren O, Jansson L, Andersson A. Effects of hyperglycemia on function of isolated mouse pancreatic islets transplanted under kidney capsule. Diabetes 1989; 38(4): 510.
7. Keymeulen B, Vetri M, Gorus F, et al. The effect of insulin treatment on function of intraportally grafted islets in streptozotocin-diabetic rats. Transplantation 1993; 56(1): 60.
8. Juang JH, Bonner-Weir S, Wu YJ, Weir GC. Beneficial influence of glycemic control upon the growth and function of transplanted islets. Diabetes 1994; 43(11): 1334.
9. Gray DW, Cranston D, McShane P, et al. The effect of hyperglycemia on pancreatic islets transplanted into rats beneath the kidney capsule. Diabetologia 1989; 32(9): 663.
10. Moore WV, Bieser K, Geng Z, et al. Decreased survival of islet allografts in rats with advanced chronic complications of diabetes. Cell Transplant 2002; 11(7): 707.
11. Davalli AM, Scaglia L, Zangen DH, et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45(9): 1161.
12. Matschinsky FM. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996; 45(2): 223.
13. Weir GC, Laybutt DR, Kaneto H, et al. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001; 50 (Suppl 1): S154.